Cargando…
A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up
Mesenchymal stem cells (MSC) are emerging as an effective therapeutic tool in treating canine osteoarthritis (OA). In this report, we focused on the questions of whether MSC transplantation has long-term beneficial effects for the improvement in motion and also evaluated the safety of MSC injection....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438407/ https://www.ncbi.nlm.nih.gov/pubmed/32903517 http://dx.doi.org/10.3389/fvets.2020.00510 |
_version_ | 1783572789149564928 |
---|---|
author | Kriston-Pál, Éva Haracska, Lajos Cooper, Paul Kiss-Tóth, Endre Szukacsov, Valéria Monostori, Éva |
author_facet | Kriston-Pál, Éva Haracska, Lajos Cooper, Paul Kiss-Tóth, Endre Szukacsov, Valéria Monostori, Éva |
author_sort | Kriston-Pál, Éva |
collection | PubMed |
description | Mesenchymal stem cells (MSC) are emerging as an effective therapeutic tool in treating canine osteoarthritis (OA). In this report, we focused on the questions of whether MSC transplantation has long-term beneficial effects for the improvement in motion and also evaluated the safety of MSC injection. Visceral adipose tissue, a surgical waste obtained during routine ovariectomy served as a source of allogeneic MSCs and used to treat OA. Altogether, fifty-eight dogs were transplanted in the study suffering from OA in the elbow (42 animals), hip (5), knee (8), ankle (2), and hock (1). The effect of MSC transplantation was evaluated by the degree of lameness at a 4-5-years follow-up period based on the owners' subjective observations. The results showed that 83% of the OA patients improved or retained improvement in lameness. Clinical safety of the treatment was assessed by evaluating the coincidence of tumors or other diseases and other adverse reactions (such as local inflammation) after MSC cell therapy. Two incidences of local inflammation for <1 week at the site of injection were reported. No other adverse reactions were detected post-treatment. Sixteen dogs died during the study, 4 due to cancer and 12 due to other diseases, diagnosed by veterinarians. Overall, our survey suggests that MSC transplantation has long-term beneficial effects in reducing lameness. Moreover, no enrichment in a specific cause of death was observed in the transplanted animals, compared to reported literature. Our data suggest that MSC treatment could be an effective and safe long-term therapy for canine OA. |
format | Online Article Text |
id | pubmed-7438407 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74384072020-09-03 A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up Kriston-Pál, Éva Haracska, Lajos Cooper, Paul Kiss-Tóth, Endre Szukacsov, Valéria Monostori, Éva Front Vet Sci Veterinary Science Mesenchymal stem cells (MSC) are emerging as an effective therapeutic tool in treating canine osteoarthritis (OA). In this report, we focused on the questions of whether MSC transplantation has long-term beneficial effects for the improvement in motion and also evaluated the safety of MSC injection. Visceral adipose tissue, a surgical waste obtained during routine ovariectomy served as a source of allogeneic MSCs and used to treat OA. Altogether, fifty-eight dogs were transplanted in the study suffering from OA in the elbow (42 animals), hip (5), knee (8), ankle (2), and hock (1). The effect of MSC transplantation was evaluated by the degree of lameness at a 4-5-years follow-up period based on the owners' subjective observations. The results showed that 83% of the OA patients improved or retained improvement in lameness. Clinical safety of the treatment was assessed by evaluating the coincidence of tumors or other diseases and other adverse reactions (such as local inflammation) after MSC cell therapy. Two incidences of local inflammation for <1 week at the site of injection were reported. No other adverse reactions were detected post-treatment. Sixteen dogs died during the study, 4 due to cancer and 12 due to other diseases, diagnosed by veterinarians. Overall, our survey suggests that MSC transplantation has long-term beneficial effects in reducing lameness. Moreover, no enrichment in a specific cause of death was observed in the transplanted animals, compared to reported literature. Our data suggest that MSC treatment could be an effective and safe long-term therapy for canine OA. Frontiers Media S.A. 2020-08-13 /pmc/articles/PMC7438407/ /pubmed/32903517 http://dx.doi.org/10.3389/fvets.2020.00510 Text en Copyright © 2020 Kriston-Pál, Haracska, Cooper, Kiss-Tóth, Szukacsov and Monostori. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Veterinary Science Kriston-Pál, Éva Haracska, Lajos Cooper, Paul Kiss-Tóth, Endre Szukacsov, Valéria Monostori, Éva A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up |
title | A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up |
title_full | A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up |
title_fullStr | A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up |
title_full_unstemmed | A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up |
title_short | A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up |
title_sort | regenerative approach to canine osteoarthritis using allogeneic, adipose-derived mesenchymal stem cells. safety results of a long-term follow-up |
topic | Veterinary Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438407/ https://www.ncbi.nlm.nih.gov/pubmed/32903517 http://dx.doi.org/10.3389/fvets.2020.00510 |
work_keys_str_mv | AT kristonpaleva aregenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup AT haracskalajos aregenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup AT cooperpaul aregenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup AT kisstothendre aregenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup AT szukacsovvaleria aregenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup AT monostorieva aregenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup AT kristonpaleva regenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup AT haracskalajos regenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup AT cooperpaul regenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup AT kisstothendre regenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup AT szukacsovvaleria regenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup AT monostorieva regenerativeapproachtocanineosteoarthritisusingallogeneicadiposederivedmesenchymalstemcellssafetyresultsofalongtermfollowup |